|
1
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, et al: The epidemiology of glioma in adults: A ‘state of the
science’ review. Neuro Oncol. 16:896–913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zagzag D, Salnikow K, Chiriboga L, Yee H,
Lan L, Ali MA, Garcia R, Demaria S and Newcomb EW: Downregulation
of major histocompatibility complex antigens in invading glioma
cells: Stealth invasion of the brain. Lab Invest. 85:328–341. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li J, Yuan J, Yuan X, Zhao J, Zhang Z,
Weng L and Liu J: MicroRNA-200b inhibits the growth and metastasis
of glioma cells via targeting ZEB2. Int J Oncol. 48:541–550. 2016.
View Article : Google Scholar
|
|
4
|
Noy R and Pollard JW: Tumor-associated
macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sainz B Jr, Alcala S, Garcia E,
Sanchez-Ripoll Y, Azevedo MM, Cioffi M, Tatari M, Miranda-Lorenzo
I, Hidalgo M, Gomez-Lopez G, et al: Microenvironmental
hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by
activating its cancer stem cell compartment. Gut. 64:1921–1935.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Molina JR, Hayashi Y, Stephens C and
Georgescu MM: Invasive glioblastoma cells acquire stemness and
increased Akt activation. Neoplasia. 12:453–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hwang RF, Moore T, Arumugam T,
Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD:
Cancer-associated stromal fibroblasts promote pancreatic tumor
progression. Cancer Res. 68:918–926. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heusinkveld M and van der Burg SH:
Identification and manipulation of tumor associated macrophages in
human cancers. J Transl Med. 9:2162011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Steinman RM and Idoyaga J: Features of the
dendritic cell lineage. Immunol Rev. 234:5–17. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sica A, Larghi P, Mancino A, Rubino L,
Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P and Mantovani
A: Macrophage polarization in tumour progression. Semin Cancer
Biol. 18:349–355. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hamilton TA, Zhao C, Pavicic PG Jr and
Datta S: Myeloid colony-stimulating factors as regulators of
macrophage polarization. Front Immunol. 5:5542014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sielska M, Przanowski P, Wylot B,
Gabrusiewicz K, Maleszewska M, Kijewska M, Zawadzka M, Kucharska J,
Vinnakota K, Kettenmann H, et al: Distinct roles of CSF family
cytokines in macrophage infiltration and activation in glioma
progression and injury response. J Pathol. 230:310–321. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Staudt ND, Jo M, Hu J, Bristow JM, Pizzo
DP, Gaultier A, VandenBerg SR and Gonias SL: Myeloid cell receptor
LRP1/CD91 regulates monocyte recruitment and angiogenesis in
tumors. Cancer Res. 73:3902–3912. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ling EA and Wong WC: The origin and nature
of ramified and amoeboid microglia: A historical review and current
concepts. Glia. 7:9–18. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Komohara Y, Ohnishi K, Kuratsu J and
Takeya M: Possible involvement of the M2 anti-inflammatory
macrophage phenotype in growth of human gliomas. J Pathol.
216:15–24. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gocheva V, Wang HW, Gadea BB, Shree T,
Hunter KE, Garfall AL, Berman T and Joyce JA: IL-4 induces
cathepsin protease activity in tumor-associated macrophages to
promote cancer growth and invasion. Genes Dev. 24:241–255. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li D, Wang X, Wu JL, Quan WQ, Ma L, Yang
F, Wu KY and Wan HY: Tumor-produced versican V1 enhances
hCAP18/LL-37 expression in macrophages through activation of TLR2
and vitamin D3 signaling to promote ovarian cancer progression in
vitro. PLoS One. 8:e566162013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen
L, Xiao HL, Wang B, Yi L, Wang QL, et al: Tumor-associated
microglia/macrophages enhance the invasion of glioma stem-like
cells via TGF-beta1 signaling pathway. J Immunol. 189:444–453.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morford LA, Dix AR, Brooks WH and Roszman
TL: Apoptotic elimination of peripheral T lymphocytes in patients
with primary intracranial tumors. J Neurosurg. 91:935–946. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bruna A, Darken RS, Rojo F, Ocaña A,
Peñuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J and
Seoane J: High TGFbeta-Smad activity confers poor prognosis in
glioma patients and promotes cell proliferation depending on the
methylation of the PDGF-B gene. Cancer Cell. 11:147–160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Massagué J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bierie B and Moses HL: Transforming growth
factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth
Factor Rev. 21:49–59. 2010. View Article : Google Scholar
|
|
26
|
Jun F, Hong J, Liu Q, Guo Y, Liao Y, Huang
J, Wen S and Shen L: Epithelial membrane protein 3 regulates TGF-β
signaling activation in CD44-high glioblastoma. Oncotarget.
8:14343–14358. 2017. View Article : Google Scholar
|
|
27
|
Araki S, Eitel JA, Batuello CN,
Bijangi-Vishehsaraei K, Xie XJ, Danielpour D, Pollok KE, Boothman
DA and Mayo LD: TGF-beta1-induced expression of human Mdm2
correlates with late-stage metastatic breast cancer. J Clin Invest.
120:290–302. 2010. View
Article : Google Scholar
|
|
28
|
Donkor MK, Sarkar A, Savage PA, Franklin
RA, Johnson LK, Jungbluth AA, Allison JP and Li MO: T cell
surveillance of oncogene-induced prostate cancer is impeded by T
cell-derived TGF-β1 cytokine. Immunity. 35:123–134. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ikushima H, Todo T, Ino Y, Takahashi M,
Miyazawa K and Miyazono K: Autocrine TGF-beta signaling maintains
tumori-genicity of glioma-initiating cells through Sry-related
HMG-box factors. Cell Stem Cell. 5:504–514. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moustakas A and Heldin CH: The regulation
of TGFbeta signal transduction. Development. 136:3699–3714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feng XH and Derynck R: Specificity and
versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev
Biol. 21:659–693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Garros-Regulez L, Aldaz P, Arrizabalaga O,
Moncho-Amor V, Carrasco-Garcia E, Manterola L, Moreno-Cugnon L,
Barrena C, Villanua J, Ruiz I, et al: mTOR inhibition decreases
SOX2-SOX9 mediated glioma stem cell activity and temozolomide
resistance. Expert Opin Ther Targets. 20:393–405. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Alonso MM, Diez-Valle R, Manterola L,
Rubio A, Liu D, Cortes-Santiago N, Urquiza L, Jauregi P, Lopez de
Munain A, Sampron N, et al: Genetic and epigenetic modifications of
Sox2 contribute to the invasive phenotype of malignant gliomas.
PLoS One. 6:e267402011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Garros-Regulez L, Garcia I,
Carrasco-Garcia E, Lantero A, Aldaz P, Moreno-Cugnon L,
Arrizabalaga O, Undabeitia J, Torres-Bayona S, Villanua J, et al:
Targeting SOX2 as a therapeutic strategy in glioblastoma. Front
Oncol. 6:2222016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang WC, Chan ML, Chen MJ, Tsai TH and
Chen YJ: Modulation of macrophage polarization and lung cancer cell
stemness by MUC1 and development of a related small-molecule
inhibitor pterostilbene. Oncotarget. 7:39363–39375. 2016.PubMed/NCBI
|
|
36
|
Lonardo E, Hermann PC, Mueller MT, Huber
S, Balic A, Miranda-Lorenzo I, Zagorac S, Alcala S,
Rodriguez-Arabaolaza I, Ramirez JC, et al: Nodal/Activin signaling
drives self-renewal and tumorigenicity of pancreatic cancer stem
cells and provides a target for combined drug therapy. Cell Stem
Cell. 9:433–446. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lonardo E, Frias-Aldeguer J, Hermann PC
and Heeschen C: Pancreatic stellate cells form a niche for cancer
stem cells and promote their self-renewal and invasiveness. Cell
Cycle. 11:1282–1290. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cabarcas SM, Mathews LA and Farrar WL: The
cancer stem cell niche-there goes the neighborhood. Int J Cancer.
129:2315–2327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Solinas G, Schiarea S, Liguori M, Fabbri
M, Pesce S, Zammataro L, Pasqualini F, Nebuloni M, Chiabrando C,
Mantovani A and Allavena P: Tumor-conditioned macrophages secrete
migration-stimulating factor: A new marker for M2-polarization,
influencing tumor cell motility. J Immunol. 185:642–652. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang J, Liao D, Chen C, Liu Y, Chuang TH,
Xiang R, Markowitz D, Reisfeld RA and Luo Y: Tumor-associated
macrophages regulate murine breast cancer stem cells through a
novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells.
31:248–258. 2013. View Article : Google Scholar
|
|
41
|
Rudin CM, Durinck S, Stawiski EW, Poirier
JT, Modrusan Z, Shames DS, Bergbower EA, Guan Y, Shin J, Guillory
J, et al: Comprehensive genomic analysis identifies SOX2 as a
frequently amplified gene in small-cell lung cancer. Nat Genet.
44:1111–1116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Leis O, Eguiara A, Lopez-Arribillaga E,
Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R
and Martin AG: Sox2 expression in breast tumours and activation in
breast cancer stem cells. Oncogene. 31:1354–1365. 2012. View Article : Google Scholar
|
|
43
|
Vervoort SJ, Lourenço AR, van Boxtel R and
Coffer PJ: SOX4 mediates TGF-β-induced expression of mesenchymal
markers during mammary cell epithelial to mesenchymal transition.
PLoS One. 8:e532382013. View Article : Google Scholar
|
